Published in J Clin Child Adolesc Psychol on December 01, 2002
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study. J Clin Psychiatry (2010) 1.67
Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord (2006) 1.65
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59
The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol (2008) 1.23
The assessment of children and adolescents with bipolar disorder. Child Adolesc Psychiatr Clin N Am (2009) 1.07
A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents. Psychopharmacology (Berl) (2013) 0.89
Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study. J Child Adolesc Psychopharmacol (2015) 0.88
Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatr Dis Treat (2008) 0.86
Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy. J Affect Disord (2010) 0.85
Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders. J Am Acad Child Adolesc Psychiatry (2013) 0.84
Anxiety in children with mood disorders: a treatment help or hindrance? J Abnorm Child Psychol (2012) 0.83
Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res (2012) 0.82
Aberrant amygdala intrinsic functional connectivity distinguishes youths with bipolar disorder from those with severe mood dysregulation. Psychiatry Res (2014) 0.82
Predictors and moderators in the randomized trial of multifamily psychoeducational psychotherapy for childhood mood disorders. J Clin Child Adolesc Psychol (2013) 0.82
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol (2013) 0.80
Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD. J Am Acad Child Adolesc Psychiatry (2014) 0.79
Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder. J Child Adolesc Psychopharmacol (2011) 0.78
Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder. J Child Adolesc Psychopharmacol (2013) 0.78
Initiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorder. Bipolar Disord (2008) 0.78
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of Children. J Clin Child Adolesc Psychol (2014) 0.78
Manic symptoms in youth with bipolar disorder: factor analysis by age of symptom onset and current age. J Affect Disord (2012) 0.78
Predicting Therapeutic Effects of Psychodiagnostic Assessment Among Children and Adolescents Participating in Randomized Controlled Trials. J Clin Child Adolesc Psychol (2016) 0.77
The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School. J Child Adolesc Psychopharmacol (2016) 0.77
Portability of a screener for pediatric bipolar disorder to a diverse setting. Psychol Assess (2011) 0.76
Sleep-Wake Patterns of Adolescents with Borderline Personality Disorder and Bipolar Disorder. Child Psychiatry Hum Dev (2016) 0.76
Validity of the Expressed Emotion Adjective Checklist (EEAC) in Caregivers of Children with Mood Disorders. Couple Family Psychol (2015) 0.75
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial. Paediatr Drugs (2016) 0.75
A developmental approach to dimensional expression of psychopathology in child and adolescent offspring of parents with bipolar disorder. Eur Child Adolesc Psychiatry (2017) 0.75
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07
Screening for bipolar disorder in the community. J Clin Psychiatry (2003) 4.24
Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 3.79
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol (2006) 3.77
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry (2006) 3.68
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry (2004) 3.44
Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry (2008) 3.30
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80
Validation of proposed DSM-5 criteria for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry (2011) 2.72
Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol (2006) 2.64
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 2.63
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2007) 2.49
Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry (2006) 2.19
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry (2006) 2.17
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics (2009) 2.13
Validity of the mood disorder questionnaire: a general population study. Am J Psychiatry (2003) 2.10
Growing evidence to support early intervention in early onset bipolar disorder. Aust N Z J Psychiatry (2007) 2.09
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry (2009) 1.96
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry (2007) 1.88
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry (2004) 1.86
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry (2003) 1.84
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry (2007) 1.82
Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord (2005) 1.78
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry (2014) 1.78
Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiatry (2005) 1.69
Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull (2007) 1.69
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry (2006) 1.68
Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents. J Clin Psychiatry (2006) 1.64
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2005) 1.64
Prevalence and predictors of PTSD and depression among adolescent victims of the Spring 2011 tornado outbreak. J Child Psychol Psychiatry (2014) 1.63
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry (2003) 1.63
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. J Am Acad Child Adolesc Psychiatry (2012) 1.62
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry (2002) 1.60
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord (2009) 1.60
Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis. Bipolar Disord (2008) 1.59
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry (2009) 1.59
Gender differences in criminality: bipolar disorder with co-occurring substance abuse. J Am Acad Psychiatry Law (2005) 1.59
Developing a 10-item mania scale from the Parent General Behavior Inventory for children and adolescents. J Clin Psychiatry (2008) 1.58
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry (2005) 1.56
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.56
Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings. Bipolar Disord (2005) 1.56
Prevalence and correlates of dating violence in a national sample of adolescents. J Am Acad Child Adolesc Psychiatry (2008) 1.55
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry (2005) 1.53
Toward an evidence-based assessment of pediatric bipolar disorder. J Clin Child Adolesc Psychol (2005) 1.50
National prevalence of posttraumatic stress disorder among sexually revictimized adolescent, college, and adult household-residing women. Arch Gen Psychiatry (2012) 1.49
Comparing the diagnostic accuracy of six potential screening instruments for bipolar disorder in youths aged 5 to 17 years. J Am Acad Child Adolesc Psychiatry (2004) 1.48
Discriminative validity of a parent version of the Young Mania Rating Scale. J Am Acad Child Adolesc Psychiatry (2002) 1.48
Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results. J Clin Psychiatry (2010) 1.47
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Br J Psychiatry (2004) 1.46
Guns, adolescents, and mental illness. Am J Psychiatry (2008) 1.46
Internal consistency and associated characteristics of informant discrepancies in clinic referred youths age 11 to 17 years. J Clin Child Adolesc Psychol (2011) 1.46
Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J Clin Psychiatry (2015) 1.44
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry (2004) 1.44
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry (2016) 1.43
Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry (2004) 1.40
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry (2003) 1.39
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol (2004) 1.38
Recent placebo-controlled acute trials in bipolar depression: focus on methodology. Int J Neuropsychopharmacol (2003) 1.38
Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry (2007) 1.36
Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry (2004) 1.34
Longitudinal pathways of victimization, substance use, and delinquency: findings from the National Survey of Adolescents. Addict Behav (2011) 1.34
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry (2007) 1.34
Taxometric Investigation of PTSD: data from two nationally representative samples. Behav Ther (2006) 1.31
Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda. J Clin Psychiatry (2006) 1.31
Validation of the Italian version of the "Mood Disorder Questionnaire" for the screening of bipolar disorders. Clin Pract Epidemiol Ment Health (2005) 1.29
A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics (2002) 1.28
Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry (2005) 1.28
Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry (2004) 1.27
Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Clin Psychiatry (2011) 1.25
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry (2006) 1.24
Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry (2012) 1.23
Who are the comorbid adolescents? Agreement between psychiatric diagnosis, youth, parent, and teacher report. J Abnorm Child Psychol (2003) 1.23
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol (2007) 1.21
Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord (2010) 1.21
Early symptoms of mania and the role of parental risk. Bipolar Disord (2005) 1.20
The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. J Child Psychol Psychiatry (2009) 1.20
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol (2008) 1.19
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility. J Child Adolesc Psychopharmacol (2003) 1.18